GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business

2

Oct 5 (Reuters) – Medical device maker GE HealthCare said on Monday it would buy privately held Sofie Biosciences for $945 million in cash, in a move that strengthens its ability to manufacture and

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)